Cargando…
Troponin I, a risk factor indicating more severe pneumonia among patients with novel coronavirus infected pneumonia
BACKGROUND: In December 2019, a novel communicable disease, novel coronavirus infected pneumonia (NCIP) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) broke out. We aimed to analyze the characteristics and severity of patients with myocardial damage in NCIP. METHODS: We enrol...
Autores principales: | Liu, Dong, Yang, Qingyuan, Chen, Wei, Chen, Hong, Feng, Yun, Hu, Weiping, Xie, Yusang, Lin, Huihuang, Yan, Jiayang, Qu, Jieming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of British Infection Association.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329679/ https://www.ncbi.nlm.nih.gov/pubmed/32838294 http://dx.doi.org/10.1016/j.clinpr.2020.100037 |
Ejemplares similares
-
The mNCP-SPI Score Predicting Risk of Severe COVID-19 among Mild-Pneumonia Patients on Admission
por: Guo, Lingxi, et al.
Publicado: (2020) -
High-Sensitivity Troponin I is an Indicator of Poor Prognosis in Patients with Severe COVID-19 Related Pneumonia
por: Liu, Yongjun, et al.
Publicado: (2022) -
Glucocorticosteroid in Treatment of Severe Pneumonia
por: Ariani, Felinda, et al.
Publicado: (2013) -
Troponin Levels and the Severity of COVID-19 Pneumonia
por: Alhindi, Turki, et al.
Publicado: (2022) -
Deep learning for differentiating novel coronavirus pneumonia and influenza pneumonia
por: Zhou, Min, et al.
Publicado: (2021)